Raptiva Linked to PML

FDA MedWatch – 2009 Safety Alerts for Human Medical Products

Raptiva (efalizumab) Update.

There have been three confirmed, and one possible report of progressive multifocal leukoencephalopathy (PML), a rare brain infection, linked to the use of this psoriasis drug.  Underwriters are advised to watch for any indications of cerebral dysfunction in applicants taking Raptiva.

Leave a comment